Citations as recorded by:

1. Scopolin ameliorates high-fat diet induced hepatic steatosis in mice: potential involvement of SIRT1-mediated signaling cascades in the liver

Sci Rep, 2017, 7(1)

DOI: 10.1038/s41598-017-02416-6

Citations as recorded by: Cross Ref PMC

2. Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition

Sci Rep, 2017, 7(1)

DOI: 10.1038/s41598-017-08899-7

Citations as recorded by: Cross Ref PMC

3. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

WJG, 2017, 23(36) p. 6549

DOI: 10.3748/wjg.v23.i36.6549

Citations as recorded by: Cross Ref

4. MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)

Med Sci Monit, 2017, 23 p. 2299

DOI: 10.12659/MSM.901377

Citations as recorded by: Cross Ref PMC

5. Oxidative Stress-Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy

Oxid Med Cell Longev, 2017, 2017

DOI: 10.1155/2017/9702820

Citations as recorded by: PMC

6. Emerging roles of SIRT1 in fatty liver diseases

Int J Biol Sci, 2017, 13 p. 852

DOI: 10.7150/ijbs.19370

Citations as recorded by: PMC

7. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats

PLoS ONE, 2017, 12(8) p. e0183541

DOI: 10.1371/journal.pone.0183541

Citations as recorded by: Cross Ref PMC

8. (-)-Epicatechin regulates blood lipids and attenuates hepatic steatosis in rats fed high-fat diet

Mol. Nutr. Food Res.,

DOI: 10.1002/mnfr.201700303

Citations as recorded by: Cross Ref

9. Resveratrol supplementation improves lipid and glucose metabolism in high-fat diet-fed blunt snout bream

Fish Physiol Biochem,

DOI: 10.1007/s10695-017-0421-9

Citations as recorded by: Cross Ref

10. Effects of Berberine on Hepatic Sirtuin 1-uncoupling Protein 2 Pathway in Non-alcoholic Fatty Liver Disease Rats Induced by High-fat Diet

Chinese Herbal Medicines, 2016, 8(4) p. 359

DOI: 10.1016/S1674-6384(16)60063-1

Citations as recorded by: Cross Ref

11. Cysteine cathepsins control hepatic NF-κB-dependent inflammation via sirtuin-1 regulation

Cell Death Dis, 2016, 7(11) p. e2464

DOI: 10.1038/cddis.2016.368

Citations as recorded by: Cross Ref PMC

12. SIRT1 and insulin resistance

Journal of Diabetes and its Complications, 2016, 30(1) p. 178

DOI: 10.1016/j.jdiacomp.2015.08.022

Citations as recorded by: Cross Ref Google

13. Sirtuins and nonalcoholic fatty liver disease

WJG, 2016, 22(46) p. 10084

DOI: 10.3748/wjg.v22.i46.10084

Citations as recorded by: Cross Ref PMC

14. SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells

Med Sci Monit, 2016, 22 p. 1593

DOI: 10.12659/MSM.896697

Citations as recorded by: Cross Ref PMC

15. A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice

Int J Hepatol, 2016, 2016

DOI: 10.1155/2016/9185987

Citations as recorded by: PMC

16. Molecular Pathogenesis of NASH

IJMS, 2016, 17(10) p. 1575

DOI: 10.3390/ijms17091575

Citations as recorded by: Cross Ref PMC Google

17. Non-alcoholic fatty liver disease in 2015

World J Hepatol, 2015, 7 p. 1450

DOI: 10.4254/wjh.v7.i11.1450

Citations as recorded by: Cross Ref PMC Google

18. Brown AlgaEcklonia cavaPolyphenol Extract Ameliorates Hepatic Lipogenesis, Oxidative Stress, and Inflammation by Activation of AMPK and SIRT1 in High-Fat Diet-Induced Obese Mice

J. Agric. Food Chem., 2015, 63(1) p. 349

DOI: 10.1021/jf502830b

Citations as recorded by: Cross Ref

19. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway

Mol. Nutr. Food Res., 2015, 59(8) p. 1443

DOI: 10.1002/mnfr.201500016

Citations as recorded by: Cross Ref Google

20. Exerts Anti-Inflammatory Effects in a Rat Model of Nonalcoholic Fatty Liver Disease

Evid Based Complement Alternat Med, 2015, 2015

DOI: 10.1155/2015/810369

Citations as recorded by: PMC

21. Potential Epigenetic Mechanism in Non-Alcoholic Fatty Liver Disease

IJMS, 2015, 16(3) p. 5161

DOI: 10.3390/ijms16035161

Citations as recorded by: Cross Ref PMC Google

22. The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease.

Mini Rev Med Chem, 2015, 15 p. 1

Citations as recorded by: Google

23. Stem Cell Transplantation Upregulates Sirt1 and Antioxidant Expression, Ameliorating Fatty Liver in Type 2 Diabetic Mice

Int J Biol Sci, 2015, 11 p. 472

DOI: 10.7150/ijbs.10809

Citations as recorded by: PMC Google

24. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice

Year: 2015

Citations as recorded by: Google

25. Does bromocriptine play a role in decreasing oxidative stress for early weaned programmed obesity?

Life Sciences, 2014, 95(1) p. 14

DOI: 10.1016/j.lfs.2013.12.013

Citations as recorded by: Cross Ref Google

26. Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease

Food and Chemical Toxicology, 2014, 63 p. 166

DOI: 10.1016/j.fct.2013.08.036

Citations as recorded by: Cross Ref Google

27. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

World J Hepatol, 2014, 6 p. 188

DOI: 10.4254/wjh.v6.i4.188

Citations as recorded by: PMC Google

28. SIRT3 as a Regulator of Non-alcoholic Fatty Liver Disease

J Lifestyle Med, 2014, 4 p. 80

DOI: 10.15280/jlm.2014.4.2.80

Citations as recorded by: PMC Google

29. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation

Nutrition, 2014, 30(7-8) p. 915

DOI: 10.1016/j.nut.2013.11.016

Citations as recorded by: Cross Ref Google

30. Dietary Blueberry and Bifidobacteria Attenuate Nonalcoholic Fatty Liver Disease in Rats by Affecting SIRT1-Mediated Signaling Pathway

Oxid Med Cell Longev, 2014, 2014

DOI: 10.1155/2014/469059

Citations as recorded by: PMC Google

31. Nonalcoholic Fatty Liver Disease: Pathogenesis and Therapeutics from a Mitochondria-Centric Perspective

Oxid Med Cell Longev, 2014, 2014

DOI: 10.1155/2014/637027

Citations as recorded by: PMC Google

32. Role of Mitochondria in Nonalcoholic Fatty Liver Disease

IJMS, 2014, 15(5) p. 8713

DOI: 10.3390/ijms15058713

Citations as recorded by: Cross Ref PMC Google

33. A potential treatment of non-alcoholic fatty liver disease with SIRT1 activators

Year: 2014

Citations as recorded by: Google

34. Brown Alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet- …

Year: 2014

Citations as recorded by: Google

35. Shift Work or Food Intake during the Rest Phase Promotes Metabolic Disruption and Desynchrony of Liver Genes in Male Rats

PLoS One, 2013, 8

DOI: 10.1371/journal.pone.0060052

Citations as recorded by: PMC Google

36. Negative regulation of inflammation by SIRT1

Pharmacological Research, 2013, 67(1) p. 60

DOI: 10.1016/j.phrs.2012.10.010

Citations as recorded by: Cross Ref Google

37. The expanding role of fish models in understanding non-alcoholic fatty liver disease

Dis Model Mech, 2013, 6 p. 905

DOI: 10.1242/dmm.011981

Citations as recorded by: PMC Google

38. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease

Journal of Hepatology, 2013, 58(1) p. 119

DOI: 10.1016/j.jhep.2012.08.008

Citations as recorded by: Cross Ref Google

39. Upregulation of Sirt1 in carbon-tetrachloride–induced acute liver injury

Drug and Chemical Toxicology, 2013, 36(3) p. 277

DOI: 10.3109/01480545.2012.710630

Citations as recorded by: Cross Ref Google

40. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine

Journal of Biomolecular Structure and Dynamics, 2013, 31(11) p. 1207

DOI: 10.1080/07391102.2012.726191

Citations as recorded by: Cross Ref Google

41. Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease

Journal of Traditional and Complementary Medicine, 2013, 3(2) p. 88

DOI: 10.4103/2225-4110.110411

Citations as recorded by: Cross Ref PMC Google

42. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease

Seminars in Cancer Biology, 2013, 23(6) p. 471

DOI: 10.1016/j.semcancer.2013.08.010

Citations as recorded by: Cross Ref Google

43. Liver physiology and liver diseases in the elderly

World J Gastroenterol, 2013, 19 p. 8459

DOI: 10.3748/wjg.v19.i46.8459

Citations as recorded by: PMC Google

44. Mechanism-based modulator discovery for sirtuin-catalyzed deacetylation reaction.

Mini Rev Med Chem, 2013, 13 p. 1

Citations as recorded by: Google

45. Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome.

Cardiovasc Hematol Agents Med Chem, 2013, 11 p. 2

Citations as recorded by: Google

46. The acceleration of aging and Alzheimer’s disease through the biological mechanisms behind obesity and type II diabetes

Health, 2013, 05(05) p. 913

DOI: 10.4236/health.2013.55121

Citations as recorded by: Cross Ref

47. The acceleration of aging and Alzheimer's disease through the biological mechanisms behind obesity and type II diabetes

Year: 2013

Citations as recorded by: Google

48. The Effect of Taurine on Hepatic Steatosis Induced by Thioacetamide in Zebrafish (Danio rerio)

Dig Dis Sci, 2012, 57(3) p. 675

DOI: 10.1007/s10620-011-1931-4

Citations as recorded by: Cross Ref Google

49. Parallel Down-Regulation of FOXO1, PPAR? and Adiponectin mRNA Expression in Visceral Adipose Tissue of Class III Obese Individuals

Obes Facts, 2012, 5(3) p. 452

DOI: 10.1159/000339574

Citations as recorded by: Cross Ref

50. Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation

Clinical Biochemistry, 2012, 45(9) p. 610

DOI: 10.1016/j.clinbiochem.2012.03.024

Citations as recorded by: Cross Ref Google

51. The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes

Aging (Albany NY), 2012, 4 p. 436

Citations as recorded by: PMC Google

52. Differentially expressed microRNAs in Huh-7 cells expressing HCV core genotypes 3a or 1b: Potential functions and downstream pathways

30(2) p. 374

DOI: 10.3892/ijmm.2012.991

Citations as recorded by: Cross Ref Google

53. Nutrient sensor–mediated programmed nonalcoholic fatty liver disease in low birthweight offspring

American Journal of Obstetrics and Gynecology, 2012, 207(4) p. 308.e1

DOI: 10.1016/j.ajog.2012.07.033

Citations as recorded by: Cross Ref PMC Google

54. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease

Med Sci Monit, 2012, 18(12) p. CR735

DOI: 10.12659/MSM.883601

Citations as recorded by: Cross Ref PMC Google

55. SIRT1 in metabolic syndrome: Where to target matters

Pharmacology & Therapeutics, 2012, 136(3) p. 305

DOI: 10.1016/j.pharmthera.2012.08.009

Citations as recorded by: Cross Ref Google

56. SirT1 regulates radiosensitivity of hepatoma cells differently under normoxic and hypoxic conditions

Cancer Sci, 2012, 103(7) p. 1238

DOI: 10.1111/j.1349-7006.2012.02285.x

Citations as recorded by: Cross Ref Google

57. Parallel down-regulation of FOXO1, PPARγ and adiponectin mRNA expression in visceral adipose tissue of class III obese individuals

Year: 2012

Citations as recorded by: Google

58. Sirtuin-1 mediates the obesity induced risk of common degenerative diseases: Alzheimer's disease, coronary artery disease and type 2 diabetes

Year: 2012

Citations as recorded by: Google